The groundbreaking therapy of the medication represents a significant advance in the management of diabetes mellitus type 2. Different to existing medications, tirzepatide affects two pathways – GLP-1 and GIP – https://tirzepatidepeptide588413.smblogsites.com/42167821/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment